Literature DB >> 3792675

Alterations in gastric mucosal morphology induced by long-term treatment with omeprazole in rats.

H Blom.   

Abstract

The effects of long-term treatment with omeprazole on the gastric mucosal morphology was studied. Eighty male Sprague-Dawley rats were used and divided into 4 equal groups. Half of the animals in 3 of the groups were given omeprazole, 40 mumol/kg body weight, orally once daily for 130 days. The remaining rats in these groups served as controls. Half of the rats in the fourth group were given subcutaneous injections with pentagastrin, this group received vehicle only. At the end of the treatment period, all animals were killed by vascular perfusion with fixative and the gastric corpus mucosae prepared for light and electron microscopy. Quantitative morphometry was used to evaluate eventual effects of treatment on the different epithelial cell types which are present in the corpus mucosa. Omeprazole treatment resulted in an increased mucosal thickness as a result of a proportional increase in all types of epithelial cells with the exception of the endocrine cells. These cells increased in number by 100%. A similar increase was seen after pentagastrin treatment. In the omeprazole-treated rats, there was also an increase in the size and number of pepsinogen granules within the zymogen cells. All changes in gastric mucosal morphology seen after 130 days of treatment with omeprazole turned out to be reversible and were not seen after a recovery period of 3 months.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792675     DOI: 10.1159/000199385

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

1.  Rapid quantitative assessment of gastric corpus atrophy in tissue sections.

Authors:  N C van Grieken; M M Weiss; G A Meijer; E Bloemena; J Lindeman; G J Offerhaus; S G Meuwissen; J P Baak; E J Kuipers
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 2.  Hyperplastic proliferations of enteroendocrine cells.

Authors:  Yogeshwar Dayal
Journal:  Endocr Pathol       Date:  1994-03       Impact factor: 3.943

3.  Omeprazole produces parietal cell hypertrophy and hyperplasia in humans.

Authors:  D K Driman; C Wright; G Tougas; R H Riddell
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

4.  Absence of a gastrin inhibitory factor in the IgG fraction of serum from patients with pernicious anaemia.

Authors:  J T Smith; A Garner; S E Hampson; R E Pounder
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

Review 5.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

6.  Clofibrate raises human 24 h intragastric acidity but does not affect plasma gastrin concentration.

Authors:  C J Gavey; J T Smith; C U Nwokolo; R E Pounder
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

Review 7.  Therapeutic achlorhydria and risk of gastric cancer.

Authors:  K G Wormsley
Journal:  Gastroenterol Jpn       Date:  1989-10

Review 8.  Hyperplastic proliferations of the ECL cells.

Authors:  Y Dayal
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.